Connect with:
Thursday / April 18. 2024

logo
mobile-logo
HomePosts Tagged "CMFRI"
Acquaculture, Agro Universities, Live Stock, Plant-Based Meat

The Memorandum of Understanding (MoU) outlines that the Central Marine Fisheries Research Institute (CMFRI) will research early cell line development

The Central Marine Fisheries Research Institute of India has joined forces with Neat Meatt Biotech to create high-value marine fish in bioreactors. The institute is taking on the challenge of lab-grown fish for the first time in India to tackle the increasing demand for seafood and ease the strain on wild fish stocks. To create cultivated or lab-grown fish, scientists isolate specific cells from the fish and grow them in a laboratory setting using animal component-free media.

The final goal is to have a product that mimics the flavour, texture, and nutritional benefits of traditionally raised fish. Initially, the focus will be on developing cell-based high-value marine fish species, such as kingfish, pomfret, and seer. To launch this initiative in a public-private partnership mode, CMFRI has partnered with Neat Meatt Biotech, a start-up dedicated to developing cultivated meat. Dr A Gopalakrishnan, CMFRI director, and Dr Sandeep Sharma, co-founder, and CEO of Neat Meatt Biotech, signed a memorandum of understanding (MoU) regarding the newly formed partnership.

The Memorandum of Understanding (MoU) outlines that the Central Marine Fisheries Research Institute (CMFRI) will research early cell line development. This process involves isolating and cultivating fish cells for further study and analysis. In addition, the CMFRI will be responsible for carrying out genetic, biochemical, and analytical work associated with the project. The institute is equipped with a cell culture laboratory that provides essential facilities for research in cellular biology.

The Memorandum of Understanding (MoU) outlines that

Acquaculture, Company News, India

A Memorandum of Understanding (MoU) has been signed between CMFRI and Kerala-based company Emineotech for the commercial production 

The ICAR-Central Marine Fisheries Research Institute (CMFRI) has announced that Cadalmin LivCure extract, a patent-protected nutraceutical product developed by the researchers at CMFRI from seaweeds, against non-alcoholic fatty liver disease, will hit the market soon.

A Memorandum of Understanding (MoU) has been signed between CMFRI and Kerala-based company Emineotech for the commercial production and marketing of the product.

A unique blend of 100 per cent natural bioactive ingredients extracted from select seaweeds, the product is made of an eco-friendly green technology to improve liver health, and is the ninth nutraceutical developed by the CMFRI.

According to Dr A Gopalakrishnan, CMFRI director, “Commercialisation of the product will be greatly beneficial to a large number of people suffering from non-alcoholic fatty liver disease as it helps improve liver health, reduce disposition of fatty substance and maintain other liver/lipid parameters within the clinically acceptable limits.” 

A Memorandum of Understanding (MoU) has been

India

To encompass all aspects of training, setting up of seed production/nursery facilities and devising appropriate location-specific farming methods

The ICAR-Central Marine Fisheries Research Institute, Chennai signed a Memorandum of Understanding (MoU) with the Government of Andhra Pradesh as a knowledge partner for providing technical services in marine fisheries and mariculture.

As part of the agreement, the Institute would provide technical backstopping on various aspects of seaweed farming to identified fisherfolk and entrepreneurs as an alternate enterprise. The technical assistance would encompass all aspects of training, setting up of seed production/nursery facilities and devising appropriate location-specific farming methods.

The Chief Minister of Andhra Pradesh, Y S Jagan Mohan Reddy graced the occasion.

To encompass all aspects of training, setting